PF-05089771
SIGMA/PZ0311 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 1430806-04-4
Empirical Formula (Hill Notation): C18H12Cl2FN5O3S2 · C7H8O3S
Molecular Weight: 672.56
Linear Formula: C18H12Cl2FN5O3S2 · C7H8O3S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C18H12Cl2FN5O3S2.C7H8O |
| InChI key | NVKBPDYKPNYMDR-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | ClC1=CC(C2=C(N)NN=C2)=C(O |
| solubility | DMSO: 30 mg/mL, clear |
| storage temp. | room temp |
| Biochem/physiol Actions: | PF-05089771 is a selective and potent inhibitor of the human voltage-gated sodium ion channel Nav1.7 with an IC50 value of 11 nM. PF-05089771 targets the voltage-sensing domain, preferentially interacting with, and stabilizing, inactivated channel conformations by interaction with the voltage-sensor domain (VSD) of Domain 4. Nav1.7 is expressed in sensory neurons and is critical for pain processing. PF-05089771 is being investigated for the treatment of chronic neuropathic pain. |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |

